Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

12 trials with published results (12%)

Research Maturity

54 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

8.1%

8 terminated out of 99 trials

Success Rate

87.1%

+0.6% vs benchmark

Late-Stage Pipeline

34%

34 trials in Phase 3/4

Results Transparency

22%

12 of 54 completed with results

Key Signals

12 with results87% success

Data Visualizations

Phase Distribution

75Total
Not Applicable (27)
Early P 1 (3)
P 1 (3)
P 2 (8)
P 3 (15)
P 4 (19)

Trial Status

Completed54
Unknown16
Recruiting10
Terminated8
Withdrawn6
Active Not Recruiting2

Trial Success Rate

87.1%

Benchmark: 86.5%

Based on 54 completed trials

Clinical Trials (99)

Showing 20 of 20 trials
NCT03553186Phase 3Recruiting

Tranexamic Acid in Adult Spinal Deformity Surgery

NCT05430659Active Not Recruiting

Intraoperative Estimated Blood Loss, Blood Transfusion, and Postoperative Clinical Outcomes in Patients Undergoing Non Cardiac Surgery, Siriraj Hospital

NCT07288489Phase 3Not Yet RecruitingPrimary

Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

NCT07288697Not ApplicableCompleted

Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery

NCT07217899Phase 2RecruitingPrimary

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT06078501Phase 3TerminatedPrimary

MisOpRostol Effect on Second Trimester Abortion Blood Loss

NCT03651154Not ApplicableActive Not Recruiting

Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections

NCT05077124Recruiting

Safe and Timely Antithrombotic Removal (STAR) Registry

NCT05093504Not ApplicableTerminated

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

NCT04976530Not ApplicableCompleted

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

NCT06637137Recruiting

Patient Blood Management in Patients Scheduled for Cardiac Surgery

NCT06725732Early Phase 1RecruitingPrimary

Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score

NCT05474027Phase 4Enrolling By Invitation

Reducing Hypotensive Anesthesia Use with TXA During Orthognathic Surgery

NCT01731444Phase 1RecruitingPrimary

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

NCT06647017Not ApplicableNot Yet RecruitingPrimary

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

NCT03249038CompletedPrimary

Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.

NCT06638749Phase 3Withdrawn

Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty

NCT06601582Not ApplicableRecruiting

Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil

NCT05522153Phase 1CompletedPrimary

Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study

NCT06049160Not ApplicableCompletedPrimary

Comparative Study Between Preoperative and Postoperative Rectal Misoprostol

Scroll to load more

Research Network

Activity Timeline